Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://primetherapeutics.com/w/patients-receive-targeted-cancer-treatment-quickly-leading-to-better-outcomes Example Link

Products, Specialty drugs, Stories

Patients receive targeted cancer treatment quickly, leading to better outcomes

March 24, 2025

https://primetherapeutics.com/w/patients-receive-targeted-cancer-treatment-quickly-leading-to-better-outcomes

Stories

Patients receive targeted cancer treatment quickly, leading to better outcomes

March 24, 2025

https://primetherapeutics.com/w/2025-spring-prime-therapeutics-report /spring-2025-prime-therapeutics-report

Research & Publications

Spring 2025 Prime Therapeutics Report

March 21, 2025

https://primetherapeutics.com/w/listen-now-a-behind-the-scenes-look-at-the-research-decoding-health-outcomes-at-amcp-2025

Stories

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025

March 20, 2025

The Latest

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 24, 2024

https://primetherapeutics.com/w/medical-benefit-drug-trend-prime-therapeutics-medical-pharmacy-trend-report-goes-behind-the-numbers-2024

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

October 15, 2024

https://primetherapeutics.com/w/prime-therapeutics-bolsters-its-position-as-industry-leader-with-10-research-studies-at-amcp-nexus-2024

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

October 10, 2024

https://primetherapeutics.com/w/prime-therapeutics-announces-new-cost-effective-humira-biosimilar-solutions-offering-clients-flexibility-and-choice

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

October 07, 2024

https://primetherapeutics.com/w/prime-therapeutics-llc-earns-certification-from-the-national-committee-for-quality-assurance

Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance

October 03, 2024

https://primetherapeutics.com/w/prime-therapeutics-introduces-a-bold-new-brand-and-vision-to-reimagine-pharmacy-solutions

Prime Therapeutics introduces a bold new brand and vision to reimagine pharmacy solutions

September 16, 2024

Showing 1 to 6 of 34

Categories

PA Sub-Categories

https://primetherapeutics.com/w/counterfeit-glp-1s-what-to-watch-out-for

Counterfeit GLP-1s: What to watch out for

November 18, 2024

https://primetherapeutics.com/w/amcp-nexus-in-focus-exploring-prime-s-glp-1-research-in-depth

AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

November 04, 2024

https://primetherapeutics.com/w/taking-a-closer-look-at-prime-s-glp-1-year-2-cost-of-care-findings

Taking a closer look at Prime’s GLP-1 Year-2 cost-of-care findings

October 30, 2024

https://primetherapeutics.com/w/amcp-nexus-2024-in-focus-prime-presents-keynote-specialty-pharmaceuticals-in-development-

AMCP Nexus 2024 in focus: Prime presents keynote “Specialty Pharmaceuticals in Development”

October 28, 2024

https://primetherapeutics.com/w/amcp-nexus-2024-in-focus-identifying-a-meaningful-comparison-using-propensity-score-weighting

AMCP Nexus 2024 in focus: Identifying a meaningful comparison using propensity score weighting

October 23, 2024

https://primetherapeutics.com/w/amcp-nexus-2024-in-focus-new-study-uses-social-determinants-of-health-to-better-treat-patients-with-chronic-lung-conditions

AMCP Nexus 2024 in focus: New study uses social determinants of health to better treat patients with chronic lung conditions

October 23, 2024

Showing 1 to 6 of 48

Categories

PA Sub-Categories

https://primetherapeutics.com/w/patients-receive-targeted-cancer-treatment-quickly-leading-to-better-outcomes

Patients receive targeted cancer treatment quickly, leading to better outcomes

March 24, 2025

https://primetherapeutics.com/w/listen-now-a-behind-the-scenes-look-at-the-research-decoding-health-outcomes-at-amcp-2025

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025

March 20, 2025

https://primetherapeutics.com/w/prime-therapeutics-recognizes-multiple-sclerosis-awareness-week

Prime Therapeutics recognizes Multiple Sclerosis Awareness Week

March 11, 2025

https://primetherapeutics.com/w/flexjobs-names-prime-therapeutics-among-top-100-companies-for-remote-work-for-second-consecutive-year

FlexJobs names Prime Therapeutics among top 100 companies for remote work for second consecutive year

February 27, 2025

https://primetherapeutics.com/w/listen-now-pharmacy-in-2050-how-and-why-pharmacy-industry-needs-to-evolve

LISTEN NOW: Pharmacy in 2050 — How and why the pharmacy industry needs to evolve

February 25, 2025

https://primetherapeutics.com/w/listen-now-how-prime-therapeutics-combats-fraud-waste-and-abuse-in-health-care

LISTEN NOW: How Prime Therapeutics combats fraud, waste and abuse in health care

February 06, 2025

Showing 1 to 6 of 101

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

https://primetherapeutics.com/w/prime-presents-2024-medical-pharmacy-trend-report-webinar

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

October 01, 2024

https://primetherapeutics.com/w/prime-presents-at-amcp-nexus-2024

Prime presents at AMCP Nexus 2024 on Oct. 14–17

September 30, 2024

https://primetherapeutics.com/w/prime-presents-at-medicaid-drug-rebate-program-mdrp-summit-2024-on-sept-23-25

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

September 23, 2024

https://primetherapeutics.com/w/prime-presents-at-72nd-annual-roy-a-bowers-conference

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

September 16, 2024

https://primetherapeutics.com/w/prime-presents-at-glp-1-agonists-food-is-medicine-a-new-recipe-for-success-in-treating-obesity-a-briefing-for-congress-

Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11

September 11, 2024

Showing 1 to 6 of 33

Categories

PA Sub-Categories

https://primetherapeutics.com/w/at-current-prices-glp-1s-aren-t-cost-effective-limiting-access-to-patients https://www.forbes.com/sites/joshuacohen/2025/03/17/at-current-prices-glp-1s-arent-cost-effective-limiting-access-to-patients/

Forbes: At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients

March 17, 2025

https://primetherapeutics.com/w/glp-1-players-seek-to-differentiate-in-increasingly-crowded-weight-loss-space https://www.biospace.com/drug-development/glp-1-players-seek-to-differentiate-in-increasingly-crowded-weight-loss-space

BioSpace: GLP-1 Players Seek to Differentiate in Increasingly Crowded Weight Loss Space

March 17, 2025

https://primetherapeutics.com/w/pharmacists-can-act-as-navigators-for-patients-using-digital-health-tools https://www.drugtopics.com/view/pharmacists-can-act-as-navigators-for-patients-using-digital-health-tools

Drug Topics: Pharmacists Can Act as Navigators for Patients Using Digital Health Tools

March 14, 2025

https://primetherapeutics.com/w/glp-1-side-effects-only-one-factor-driving-patient-discontinuation-rates https://www.biospace.com/drug-development/glp-1-side-effects-only-one-factor-driving-patient-discontinuation-rates

BioSpace: GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates

March 10, 2025

https://primetherapeutics.com/w/pharmacists-will-play-key-role-in-integration-of-precision-medicine https://www.drugtopics.com/view/pharmacists-will-play-key-role-in-integration-of-precision-medicine

Drug Topics: Pharmacists Will Play Key Role in Integration of Precision Medicine

March 03, 2025

https://primetherapeutics.com/w/cancer-drugs-move-from-iv-to-sc-predictions-for-2025 https://www.managedhealthcareexecutive.com/view/cancer-drugs-move-from-iv-to-sc-predictions-for-2025

Managed Healthcare Executive: Cancer Drugs Move from IV to SC | Predictions for 2025

January 14, 2025

Showing 1 to 6 of 95

Categories

PA Research & Publications

https://primetherapeutics.com/w/2025-spring-prime-therapeutics-report /spring-2025-prime-therapeutics-report

Spring 2025 Prime Therapeutics Report

March 21, 2025

https://primetherapeutics.com/w/expert-clinical-network-insights-march-2025 /expert-clinical-network-insights-march-2025

Expert Clinical Network Insights: March 2025

March 14, 2025

https://primetherapeutics.com/w/fda-decisions-expected-april-2025 /fda-decisions-expected-april-2025

FDA Decisions Expected: April 2025

March 14, 2025

https://primetherapeutics.com/w/high-cost-therapy-profile-march-2025 /high-cost-therapy-profile-march-2025

High-Cost Therapy Profile: March 2025

March 14, 2025

https://primetherapeutics.com/w/oncology-insights-march-2025 /oncology-insights-march-2025

Oncology Insights: March 2025

March 14, 2025

https://primetherapeutics.com/w/clinical-highlights-february-2025 /clinical-highlights-february-2025

Clinical Highlights: February 2025

February 28, 2025

Showing 1 to 6 of 136

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Careers

Careers Overview

Read - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

Patients receive targeted cancer treatment quickly, leading to better outcomes

Patients receive targeted cancer treatment quickly, leading to better outcomes

Spring 2025 Prime Therapeutics Report

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025

The Latest

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Prime Therapeutics announces new, cost-effective Humira® biosimilar solutions, offering clients flexibility and choice

Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance

Prime Therapeutics introduces a bold new brand and vision to reimagine pharmacy solutions

Counterfeit GLP-1s: What to watch out for

AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

Taking a closer look at Prime’s GLP-1 Year-2 cost-of-care findings

AMCP Nexus 2024 in focus: Prime presents keynote “Specialty Pharmaceuticals in Development”

AMCP Nexus 2024 in focus: Identifying a meaningful comparison using propensity score weighting

AMCP Nexus 2024 in focus: New study uses social determinants of health to better treat patients with chronic lung conditions

Patients receive targeted cancer treatment quickly, leading to better outcomes

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025

Prime Therapeutics recognizes Multiple Sclerosis Awareness Week

FlexJobs names Prime Therapeutics among top 100 companies for remote work for second consecutive year

LISTEN NOW: Pharmacy in 2050 — How and why the pharmacy industry needs to evolve

LISTEN NOW: How Prime Therapeutics combats fraud, waste and abuse in health care

Prime presents at ISG Digital Business Summit on Nov. 14

Prime presents 2024 Medical Pharmacy Trend Report webinar on Oct. 24

Prime presents at AMCP Nexus 2024 on Oct. 14–17

Prime presents at Medicaid Drug Rebate Program (MDRP) Summit 2024 on Sept. 23–25

Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22

Prime presents at: GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress on Sept. 11

Forbes: At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients

BioSpace: GLP-1 Players Seek to Differentiate in Increasingly Crowded Weight Loss Space

Drug Topics: Pharmacists Can Act as Navigators for Patients Using Digital Health Tools

BioSpace: GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates

Drug Topics: Pharmacists Will Play Key Role in Integration of Precision Medicine

Managed Healthcare Executive: Cancer Drugs Move from IV to SC | Predictions for 2025

Spring 2025 Prime Therapeutics Report

Expert Clinical Network Insights: March 2025

FDA Decisions Expected: April 2025

High-Cost Therapy Profile: March 2025

Oncology Insights: March 2025

Clinical Highlights: February 2025

Login Portals

Compliance / Legal

Careers